Medicine

Reports of an "outbreak" of some as yet unidentified canine respiratory illness are scaring dog owners. But veterinarians and researchers aren't panicking.

A family in Wilmington, Delaware, faced a looming deadline to get their son a new gene therapy treatment for Duchenne muscular dystrophy.

The Children's Hospital of Philadelphia now houses a machine that is helping to make CAR T-cell therapy much less expensive.

Philly’s Community Doula Support Program launched in early 2020 in response to rising drug overdose deaths among pregnant and postpartum people.

Temple Health physicians are expanding a program to increase access to stool-based screening kits, an alternative to colonoscopies.

Anyone who did not order a batch of four COVID-19 tests in September can secure up to eight of them this time around starting Monday at COVIDtests.gov.

Despite the prevalence of autoimmune conditions, like the thyroid disease Hashimoto's, finding help can prove frustrating and expensive.

The drops were sold by CVS Health, Target, Rite Aid and other retailers.

ACA plans are now well entrenched — an estimated 16.3 million people signed up during open enrollment last year. This year may see even larger numbers.

After facing several serious illnesses, Bob Slade and partner Michael Klena, figured out their own way to cope.

Federal health officials issued the alert for six different brands of products after finding bacterial contamination at a manufacturing facility.

Brain fog, depression, joint pain, and difficulty breathing that lingers. What the latest research says about long COVID and possible treatments as millions seek answers.

National data shows COVID-19 levels are moderate. In most of the U.S., levels of other respiratory viruses are low, although RSV is ticking up in some southeastern states.

Opioid payments for county governments and county district attorney offices equaled about $6.50 per resident across the state last year. But there were big differences.

The newborn RSV antibody shots offer protection against severe illness for at least five months, but they may not be widely available until next year.